EUR 1.4
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -36.94 Million EUR | -335.97% |
2022 | 15.65 Million EUR | -84.95% |
2021 | 104 Million EUR | 231.54% |
2020 | 31.36 Million EUR | 2756.89% |
2019 | 1.09 Million EUR | 102.26% |
2018 | 542.89 Thousand EUR | 72.23% |
2017 | 315.22 Thousand EUR | 362.48% |
2016 | -120.09 Thousand EUR | 67.02% |
2015 | -364.16 Thousand EUR | 76.19% |
2014 | -1.52 Million EUR | 13.02% |
2013 | -1.75 Million EUR | -143.45% |
2012 | -722.28 Thousand EUR | -121.22% |
2011 | -326.5 Thousand EUR | -1031.01% |
2010 | -28.86 Thousand EUR | 87.14% |
2009 | -224.56 Thousand EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -21 Million EUR | 0.0% |
2023 Q4 | -17.55 Million EUR | 0.0% |
2023 FY | -36.94 Million EUR | -335.97% |
2023 Q2 | -19.39 Million EUR | 0.0% |
2022 Q2 | 30.58 Million EUR | 0.0% |
2022 FY | 15.65 Million EUR | -84.95% |
2022 Q4 | -14.97 Million EUR | 0.0% |
2021 FY | 104 Million EUR | 231.54% |
2021 Q4 | 33.51 Million EUR | 0.0% |
2021 Q2 | 70.48 Million EUR | 0.0% |
2020 FY | 31.36 Million EUR | 2756.89% |
2020 Q4 | 25.15 Million EUR | 0.0% |
2020 Q2 | 6.21 Million EUR | 0.0% |
2019 FY | 1.09 Million EUR | 102.26% |
2019 Q2 | 603.33 Thousand EUR | 0.0% |
2019 Q4 | 512.31 Thousand EUR | 0.0% |
2018 Q4 | 342.55 Thousand EUR | 0.0% |
2018 Q2 | 200.34 Thousand EUR | 0.0% |
2018 FY | 542.89 Thousand EUR | 72.23% |
2017 Q4 | -673.55 Thousand EUR | 0.0% |
2017 FY | 315.22 Thousand EUR | 362.48% |
2017 Q2 | 988.77 Thousand EUR | 0.0% |
2016 Q2 | 8021.00 EUR | 0.0% |
2016 Q4 | -128.11 Thousand EUR | 0.0% |
2016 FY | -120.09 Thousand EUR | 67.02% |
2015 FY | -364.16 Thousand EUR | 76.19% |
2015 Q2 | 546.84 Thousand EUR | 0.0% |
2015 Q4 | -911 Thousand EUR | 0.0% |
2014 Q2 | -493.17 Thousand EUR | 0.0% |
2014 FY | -1.52 Million EUR | 13.02% |
2014 Q4 | -1.03 Million EUR | 0.0% |
2013 Q1 | -439.59 Thousand EUR | 0.0% |
2013 FY | -1.75 Million EUR | -143.45% |
2013 Q4 | -1.31 Million EUR | -199.33% |
2013 Q3 | -439.59 Thousand EUR | 0.67% |
2013 Q2 | -442.54 Thousand EUR | -0.67% |
2012 Q4 | -439.59 Thousand EUR | -143.45% |
2012 FY | -722.28 Thousand EUR | -121.22% |
2012 Q1 | -180.57 Thousand EUR | 0.0% |
2012 Q2 | -180.57 Thousand EUR | 0.0% |
2012 Q3 | -180.57 Thousand EUR | 0.0% |
2011 Q1 | -81.62 Thousand EUR | 0.0% |
2011 Q2 | -81.62 Thousand EUR | 0.0% |
2011 Q3 | -81.62 Thousand EUR | 0.0% |
2011 Q4 | -180.57 Thousand EUR | -121.22% |
2011 FY | -326.5 Thousand EUR | -1031.01% |
2010 Q3 | -7217.00 EUR | 0.0% |
2010 Q1 | -7217.00 EUR | 0.0% |
2010 Q2 | -7217.00 EUR | 0.0% |
2010 Q4 | -81.62 Thousand EUR | -1031.01% |
2010 FY | -28.86 Thousand EUR | 87.14% |
2009 Q1 | -56.14 Thousand EUR | 0.0% |
2009 FY | -224.56 Thousand EUR | 0.0% |
2009 Q4 | -7217.00 EUR | 87.14% |
2009 Q3 | -56.14 Thousand EUR | 0.0% |
2009 Q2 | -56.14 Thousand EUR | 0.0% |
2008 Q4 | -56.14 Thousand EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Predilife S.A. | -4.22 Million EUR | -774.646% |
bioMérieux S.A. | 357.6 Million EUR | 110.332% |
Eurofins Scientific SE | 310.2 Million EUR | 111.91% |
Lumibird SA | 7.12 Million EUR | 618.468% |